Mizuho Maintains Outperform on Verastem, Raises Price Target to $14
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice Target
Mizuho analyst Graig Suvannavejh maintains Verastem (NASDAQ:VSTM) with a Outperform and raises the price target from $13 to $14.
Mizuho analyst Graig Suvannavejh maintains Verastem (NASDAQ:VSTM) with a Outperform and raises the price target from $13 to $14.